Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

This study is currently recruiting participants.

Study NCT00710528 Information provided by Calistoga Pharmaceuticals, Inc.

First Received: July 1, 2008 Last Updated: July 1, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2010
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)